Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2026-01-02 @ 11:38 AM
Study NCT ID:
NCT06902103
Status:
COMPLETED
Last Update Posted:
2025-03-30
First Post:
2025-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetic Study of Single and Multiple Intravenous Administration of Nalbuphine Hydrochloride Injection in Healthy Chinese Volunteers
Sponsor:
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2025-03-24
First Submit QC Date:
None
Study First Post Date:
2025-03-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-24
Last Update Post Date:
2025-03-30
Last Update Post Date Type:
ACTUAL